BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 37549105)

  • 1. Imaging Wisely Campaign: Initiative to Reduce Imaging for Low Back Pain Across a Large Safety Net System.
    Tsega S; Krouss M; Alaiev D; Talledo J; Chandra K; Shin D; Garcia M; Zaurova M; Manchego PA; Cho HJ
    J Am Coll Radiol; 2024 Jan; 21(1):165-174. PubMed ID: 37517770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reducing Overuse of 3-Day Repeat Type and Screen Testing across an 11-Hospital Safety Net System.
    Shin D; Cho HJ; Tsega S; Alaiev D; Talledo J; Chandra K; Manchego PA; Zaurova M; Garcia M; Jacobson J; Krouss M
    J Gen Intern Med; 2024 Jan; 39(1):13-18. PubMed ID: 37429975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initiative to reduce unnecessary routine daily testing of complete blood counts across 11 safety net hospitals.
    Cho HJ; Israilov S; Tsega S; Alaiev D; Talledo J; Chandra K; Alarcon Manchego P; Zaurova M; Petrilli CM; Krouss M
    Am J Clin Pathol; 2024 Apr; 161(4):388-392. PubMed ID: 38041859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Choosing Wisely and Promoting High-Value Care and Staff Safety During the COVID-19 Pandemic in a Large Safety Net System.
    Krouss M; Israilov S; Mestari N; Talledo J; Alaiev D; Moskovitz JB; Faillace RT; Uppal A; Fagan I; Curcio J; Scott J; Bouton M; Ford K; Cohen V; Wei EK; Cho HJ
    Qual Manag Health Care; 2024 Apr-Jun 01; 33(2):94-100. PubMed ID: 37817318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible role of plasma ceruloplasmin and erythrocyte sedimentation rate in assessing compliance with occupational hygiene and safety practices in waste management workers.
    Odewabi AO; Ogundahunsi OA; Odewabi AA; Oritogun KS; Ekor M
    Toxicol Int; 2013 May; 20(2):146-53. PubMed ID: 24082508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of choosing wisely recommendations on preprocedural cardiovascular testing.
    Patel K; Winchester D
    Am Heart J Plus; 2022 Jan; 13():100107. PubMed ID: 38560075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-assembling SARS-CoV-2 spike-HBsAg nanoparticles elicit potent and durable neutralizing antibody responses via genetic delivery.
    Liu C; Wang L; Merriam JS; Shi W; Yang ES; Zhang Y; Chen M; Kong WP; Cheng C; Tsybovsky Y; Stephens T; Verardi R; Leung K; Stein C; Olia AS; Harris DR; Choe M; Zhang B; Graham BS; Kwong PD; Koup RA; Pegu A; Mascola JR
    NPJ Vaccines; 2023 Aug; 8(1):111. PubMed ID: 37553406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and immunogenicity of Ad5-nCoV immunization after three-dose priming with inactivated SARS-CoV-2 vaccine in Chinese adults.
    Zhang H; Xu N; Xu Y; Qin P; Dai R; Xu B; Wang S; Ding L; Fu J; Zhang S; Hua Q; Liao Y; Yang J; Hu X; Jiang J; Lv H
    Nat Commun; 2023 Aug; 14(1):4757. PubMed ID: 37553338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-dihydrogalactochitosan reduces mortality in a lethal mouse model of SARS-CoV-2.
    Weiss CM; Liu H; Ball EE; Hoover AR; Wong TS; Wong CF; Lam S; Hode T; Keel MK; Levenson RM; Chen WR; Coffey LL
    PLoS One; 2023; 18(8):e0289139. PubMed ID: 37552656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conservative versus Liberal Oxygenation Targets in Intensive Care Unit Patients (ICONIC): A Randomized Clinical Trial.
    van der Wal LI; Grim CCA; Del Prado MR; van Westerloo DJ; Boerma EC; Rijnhart-de Jong HG; Reidinga AC; Loef BG; van der Heiden PLJ; Sigtermans MJ; Paulus F; Cornet AD; Loconte M; Schoonderbeek FJ; de Keizer NF; Bakhshi-Raiez F; Le Cessie S; Serpa Neto A; Pelosi P; Schultz MJ; Helmerhorst HJF; de Jonge E;
    Am J Respir Crit Care Med; 2023 Oct; 208(7):770-779. PubMed ID: 37552556
    [No Abstract]   [Full Text] [Related]  

  • 11. Routine statins use is associated with less adverse outcome in patients above 70 years of age admitted to hospital with COVID-19.
    Izkhakov E; Vilian Y; Buch A; Denysov V; Namouz D; Nathan A; Greenman Y; Ziv-Baran T
    BMC Geriatr; 2023 Aug; 23(1):473. PubMed ID: 37550638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platform adaptive trial of novel antivirals for early treatment of COVID-19 In the community (PANORAMIC): protocol for a randomised, controlled, open-label, adaptive platform trial of community novel antiviral treatment of COVID-19 in people at increased risk of more severe disease.
    Gbinigie O; Ogburn E; Allen J; Dorward J; Dobson M; Madden TA; Yu LM; Lowe DM; Rahman N; Petrou S; Richards D; Hood K; Patel M; Saville BR; Marion J; Holmes J; Png ME; Hayward G; Lown M; Harris V; Jani B; Hart N; Khoo S; Rutter H; Chalk J; Standing JF; Breuer J; Lavallee L; Hadley E; Cureton L; Benysek M; Andersson MI; Francis N; Thomas NPB; Evans P; van Hecke O; Koshkouei M; Coates M; Barrett S; Bateman C; Davies J; Raymundo-Wood I; Ustianowski A; Nguyen-Van-Tam J; Carson-Stevens A; Hobbs R; Little P; Butler CC
    BMJ Open; 2023 Aug; 13(8):e069176. PubMed ID: 37550022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nationwide Analysis of the Outcomes and Mortality of Hospitalized Infants with Concomitant Diagnosis of COVID-19.
    Krishnan P; Malik A; Isath A; Bandyopadhyay D; Goel A; Parton L; Chandrasekharan P; Singh M
    Am J Perinatol; 2024 May; 41(S 01):e2727-e2734. PubMed ID: 37549883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the suspension of mass drug administration during the COVID-19 pandemic on onchocerciasis prevalence in the Bandjoun and Massangam health districts, West Region of Cameroon.
    Shintouo CM; Shey RA; Yengo BN; Yaah NE; Teh RN; Ngwese RA; Ayong L; Vanhamme L; Souopgui J; Ghogomu SM; Njemini R
    Acta Trop; 2023 Oct; 246():106999. PubMed ID: 37549841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative antibody and cell-mediated immune responses, reactogenicity, and efficacy of homologous and heterologous boosting with CoronaVac and BNT162b2 (Cobovax): an open-label, randomised trial.
    Leung NHL; Cheng SMS; Cohen CA; Martín-Sánchez M; Au NYM; Luk LLH; Tsang LCH; Kwan KKH; Chaothai S; Fung LWC; Cheung AWL; Chan KCK; Li JKC; Ng YY; Kaewpreedee P; Jia JZ; Ip DKM; Poon LLM; Leung GM; Peiris JSM; Valkenburg SA; Cowling BJ
    Lancet Microbe; 2023 Sep; 4(9):e670-e682. PubMed ID: 37549680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of dapagliflozin on COVID-19 infection and risk of hospitalization.
    Salgado-Barreira A; Seijas-Amigo J; Rodriguez-Mañero M; Piñeiro-Lamas M; Eiras S; Cordero A; Gonzalez-Juanatey JR; Figueiras A
    J Antimicrob Chemother; 2023 Sep; 78(9):2335-2342. PubMed ID: 37549309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of vaccination, international travel, public health and social measures with lineage dynamics of SARS-CoV-2.
    Yang L; Wang Z; Wang L; Vrancken B; Wang R; Wei Y; Rader B; Wu CH; Chen Y; Wu P; Li B; Lin Q; Dong L; Cui Y; Shi M; Brownstein JS; Stenseth NC; Yang R; Tian H
    Proc Natl Acad Sci U S A; 2023 Aug; 120(33):e2305403120. PubMed ID: 37549270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling the kinetics of the neutralizing antibody response against SARS-CoV-2 variants after several administrations of Bnt162b2.
    Clairon Q; Prague M; Planas D; Bruel T; Hocqueloux L; Prazuck T; Schwartz O; Thiébaut R; Guedj J
    PLoS Comput Biol; 2023 Aug; 19(8):e1011282. PubMed ID: 37549192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Choosing Wisely and reducing the simultaneous ordering of erythrocyte sedimentation rate and C-reactive protein testing in a large safety net system.
    Cho HJ; Talledo J; Alaiev D; Israilov S; Chandra K; Tsega S; Garcia M; Shin DW; Zaurova M; Alarcon Manchego P; Krouss M
    Am J Clin Pathol; 2023 Dec; 160(6):585-592. PubMed ID: 37549105
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.